In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after ...

Thousands of pediatric cancer patients have benefited from cutting-edge advances in treatment, the American Association for ...

Radon, a naturally occurring radioactive gas, may be lurking in Ohio classrooms. But not every district tests for it.

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...

Radon, a naturally occurring radioactive gas, may be lurking in Ohio classrooms. But not every district tests for it.

The term leukemia, commonly known as blood cancer, is already familiar to most people. No wonder–in Germany, around 12,200 people are diagnosed with it each year. Essentially, anyone at any age can be ...

First real-world evidence for a menin inhibitor shows 77% ORR (10/13), 31% (4/13) CR/CRh, 75% (9/12) MRD negativity, and favorable tolerability ...

Graft-versus-host disease (GVHD) is a potential post-transplant complication. Here’s how one patient and his wife are ...

The Mikaela Naylon Give Kids a Chance Act now heads to the Senate, aiming to fast-track treatments and give children with ...

In a new trial, patients with B-acute lymphoblastic leukemia (B-ALL) who had no evidence of remaining cancer cells after prior treatment, experienced comparable outcomes whether they received ...

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the ...

TIBSOVO is a targeted therapy that works against an abnormal protein created by a mutation in the IDH1 gene. This abnormal ...